/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2023-03-29 14:21:362023-04-13 14:21:46Scrip Asks…What Does 2023 Hold For Biopharma? Part 10: Diversity, Equity And Inclusion (Subscription required)
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2023-03-17 14:19:442023-04-13 14:20:46Scrip Asks…What Does 2023 Hold For Biopharma? Part 8: Therapeutic Area Advances (Subscription required)
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2023-02-28 14:17:372023-04-13 14:18:18Scrip Asks…What Does 2023 Hold For Biopharma? Part 7: Clinical Trial Trends (Subscription required)
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2023-02-22 14:15:142023-04-13 14:15:36HealthLeaders: Daré Bioscience CEO Drives Culture of Transformation in Women’s Health
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2023-01-06 14:13:102023-04-13 14:13:25PharmaVoice: What’s top of mind for industry execs at JPM?
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2022-08-23 08:00:222022-09-09 18:16:45HealthLeaders: Increased Contraceptive Education Can Help Manage Impact of Roe vs. Wade
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2022-09-02 08:00:422022-09-09 18:12:37The Medicine Maker: A History of Missed Opportunity
/wp-content/uploads/2019/07/dare_logo.svg00eallison/wp-content/uploads/2019/07/dare_logo.svgeallison2022-07-05 08:00:062022-08-01 18:18:10FierceBiotech: ‘Organize. Align’: Women in biotech see Roe v. Wade ruling as a call to action